A-802715 is primarily used in research settings as a selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). Its application is significant in studying the role of sEH in various biological processes, particularly in inflammation and cardiovascular diseases. Researchers utilize A-802715 to investigate the enzyme's impact on the metabolism of epoxy fatty acids, which are involved in regulating blood pressure, inflammation, and pain. By inhibiting sEH, A-802715 helps in understanding the potential therapeutic benefits of modulating this pathway, offering insights into the development of treatments for conditions like hypertension, chronic pain, and inflammatory disorders. Its use is confined to laboratory studies and preclinical research, providing valuable data for advancing pharmacological knowledge.